We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Improving Disease Knowledge in Adolescents With Sickle Cell Disease (KNOW-IT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01945073
Recruitment Status : Completed
First Posted : September 18, 2013
Last Update Posted : December 2, 2015
Sponsor:
Information provided by (Responsible Party):
Monika Parshad-Asnani, The University of The West Indies

Tracking Information
First Submitted Date  ICMJE September 10, 2013
First Posted Date  ICMJE September 18, 2013
Last Update Posted Date December 2, 2015
Study Start Date  ICMJE August 2013
Actual Primary Completion Date April 2015   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: September 13, 2013)
Change in Disease Knowledge [ Time Frame: 3, 6 and 12 months ]
In this inquiry, we wish to apply an educational intervention to determine if there are any improvements in disease knowledge as a result among adolescents attending the Sickle Cell Unit in Jamaica. We also wish to examine if knowledge, and any changes in knowledge, will each have any association with Quality of Life and their perceptions of their illness.
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: September 13, 2013)
  • Change in Quality of Life [ Time Frame: 3, 6 and 12 months ]
  • Change in Illness Perception [ Time Frame: 3, 6 and 12 months ]
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures
 (submitted: September 13, 2013)
Predictors of change in knowledge [ Time Frame: 3, 6 and 12 months ]
Original Other Pre-specified Outcome Measures Same as current
 
Descriptive Information
Brief Title  ICMJE Improving Disease Knowledge in Adolescents With Sickle Cell Disease
Official Title  ICMJE An Educational Intervention to Improve Disease Knowledge Among Adolescents With Sickle Cell Disease
Brief Summary

Increased knowledge about an illness can increase self-management among those afflicted. In order to facilitate people with sickle cell disease living a longer and healthier life, they should be taught to manage their illness.An adolescent with a chronic illness has many unique challenges, in addition to maneuvering the turbulent adolescence period itself. It has been that better knowledge and more positive perceptions of their illness equate not only to better control of their illness but also better quality of life.Studies have also shown the benefits of self-management: when patients are responsible for managing their own illness, their clinical outcomes and quality of life improve and they become less dependent on health care services.

In this study we aim to examine if knowledge, and any changes in knowledge, will each have any association with Quality of Life (QOL) and their perceptions of their illness (IP). We also seek to investigate the effects of an educational booklet, as well as an intervention including the educational booklet with formal counselling on their knowledge, QOL and IPs.

Detailed Description

In this inquiry, we wish to apply an educational intervention to determine if there are any improvements in disease knowledge as a result among adolescents attending the Sickle Cell Unit (SCU) in Jamaica. We also wish to examine if knowledge, and any changes in knowledge, will each have any association with Quality of Life (QOL) and their perceptions of their illness (IP).

Our specific hypotheses are:

  1. Important predictors of knowledge among adolescents with Sickle Cell Disease (SCD) are gender, age, education of the adolescent as well as of the parents, socioeconomic status, frequency of attendance at SCU, rural/urban residence, and disease severity.
  2. The intervention involving training using an educational booklet specific to 'teens living with SCD' will improve knowledge among the adolescents
  3. Adding 'individual Counselling' to the intervention will increase the benefits
  4. Improvements in knowledge will translate to improvements in QOL and positive IPs.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Condition  ICMJE
  • Sickle Cell Disease
  • Quality of Life
Intervention  ICMJE
  • Behavioral: Educational Booklet (BK)
    The information booklet provides age appropriate explanation about SCD: inheritance patterns for the trait and common sickle cell disorders in the Jamaican population. It includes manifestations, complications and the necessary preventive and treatment advice. In addition, issues that are common to adolescents including sexual activity, contraceptive use, drug usage, career advice and developmental changes common to persons with the disease are also discussed.
  • Other: Formal Counselling (CB)
    The study coordinator will have a face to face counselling session, lasting about 30 minutes, with the adolescent and/or caregiver. This will include the use of the educational booklet as an education tool, as well as a thorough discussion on the disease process; its manifestations, effects, and specific concerns during the adolescent period; as well as clarification of common myths and misconceptions about the disease.
Study Arms  ICMJE
  • No Intervention: Control (RC)
    Routine clinical care with no intervention
  • Experimental: Educational Booklet (BK)
    Routine clinical care and educational booklet (BK) given
    Intervention: Behavioral: Educational Booklet (BK)
  • Experimental: Educational Booklet and Counselling (CB)
    Routine clinical care, aided by formal counselling and active discussions from the educational booklet (CB)
    Interventions:
    • Behavioral: Educational Booklet (BK)
    • Other: Formal Counselling (CB)
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: September 13, 2013)
150
Original Estimated Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE April 2015
Actual Primary Completion Date April 2015   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • All adolescent patients, ages 13-19 years inclusive, with Sickle Cell Disease that attend the Sickle Cell Unit at University of the West Indies, Mona Campus will be eligible for the study and hence will be asked to participate.

Exclusion Criteria:

  • adolescent with neurological disorders e.g. Cerebrovascular accidents or with physical or intellectual disabilities will be excluded.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 13 Years to 19 Years   (Child, Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Jamaica
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT01945073
Other Study ID Numbers  ICMJE 0000
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Current Responsible Party Monika Parshad-Asnani, The University of The West Indies
Original Responsible Party Same as current
Current Study Sponsor  ICMJE The University of The West Indies
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Monika R Parshad-Asnani, MBBS MSc DM Sickle Cell Unit, TMRI, UWI
Study Director: Jennifer Knight-Madden, MBBS PhD Sickle Cell Unit, TMRI, UWI
PRS Account The University of The West Indies
Verification Date November 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP